# Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic

NDC: 0942-9201
Generic name: Anticoagulant Citrate Phosphate Dextrose (CPD) Solution
Labeler / Manufacturer: Fenwal, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20070301

FDA application: BN170401

## Active ingredients

- ANHYDROUS CITRIC ACID: 105 mg/35mL
- DEXTROSE MONOHYDRATE: 893 mg/35mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 78 mg/35mL
- TRISODIUM CITRATE DIHYDRATE: 921 mg/35mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0942-9201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0942-9201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d55cb701-9664-4931-8754-1a8cae68da06